GRANADILLO PEDRO P

Average Profitability
2.48%
Insider Buys Quantity
4
Insider Buys Sum
$981,201.30
Insider Sells Quantity
13
Insider Sells Sum
$9.83M

Insider Activity of GRANADILLO PEDRO P

The largest purchase of all time was on 2008-11-05 and amounted to 7000 shares of Haemonetics Corporation for $405,658.

The largest sale of all time was on 2018-09-17 and amounted to 30824 shares of Haemonetics Corporation for $3.45M.

Biography of GRANADILLO PEDRO P

No biography is available at this moment.

2018-11-08SaleHaemonetics Corporation
HAE
director
12,322
0.0239%
$114.50$1.41M-10.29%
2018-09-17SaleHaemonetics Corporation
HAE
director
30,824
0.0615%
$111.83$3.45M-5.07%
2017-12-01SaleHaemonetics Corporation
HAE
director
7,118
0.0133%
$57.06$406,184+57.56%
2015-02-18SaleHaemonetics Corporation
HAE
director
11,328
0.022%
$43.45$492,161-11.45%
2014-07-07SaleHaemonetics Corporation
HAE
director
7,674
0.0149%
$35.96$275,931+5.17%
2014-06-06SaleHaemonetics Corporation
HAE
director
7,674
0.0149%
$34.69$266,234+7.47%
2014-05-07SaleHaemonetics Corporation
HAE
director
7,674
0.0145%
$31.14$238,986+14.78%
2014-04-07SaleHaemonetics Corporation
HAE
director
7,674
0.0148%
$31.98$245,432+12.69%
2014-03-10SaleHaemonetics Corporation
HAE
director
7,672
0.0149%
$36.70$281,559-1.91%
2012-11-12SaleHaemonetics Corporation
HAE
director
16,000
0.0616%
$80.40$1.29M+1.46%
2012-08-13SaleHaemonetics Corporation
HAE
director
12,000
0.0382%
$57.40$688,750+16.32%
2011-08-15SaleHaemonetics Corporation
HAE
director
1,700
0.0066%
$59.74$101,558+9.57%
2010-11-05SaleHaemonetics Corporation
HAE
director
12,000
0.0479%
$57.72$692,600+6.69%
2008-11-05PurchaseHaemonetics Corporation
HAE
director
7,000
0.0283%
$57.95$405,658-2.97%
2008-05-05PurchaseHaemonetics Corporation
HAE
director
3,600
0.014%
$53.59$192,924+4.07%
2005-11-02PurchaseHaemonetics Corporation
HAE
director
6,000
0.0226%
$48.86$293,176-0.63%
2005-09-02PurchaseHaemonetics Corporation
HAE
director
2,000
0.0077%
$44.72$89,444+9.45%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.